Development and Feasibility Testing of a Mobile Phone-Based HIV Primary Care Engagement Intervention

Columbia University

Status: Withdrawn

Conditions: HIV; Adherence

Treatments: Other: Text messaging

Study type: Interventional

Funder types: Other

Identifiers

NCT02468544

AAAO7902

Details and patient eligibility

About

This is an open-trial pilot study in which adult methadone maintenance treatment patients who are living with HIV but are not engaged in HIV primary care (i.e., missed appointments, non-adherence to medication) will be recruited to participate in a HIV primary care engagement study. The purpose of this study is to develop and test the feasibility and acceptability of a mobile phone-based health (mHealth) text messaging intervention to improve engagement in HIV primary care among substance abusing populations with HIV.

Sex: All

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Client of a methadone maintenance treatment program
• HIV positive (status confirmed by medical records)
• At least 18 years of age
• English speaking
• Comfortable using a mobile phone (to send and receive text messages)
• Lives in New York City
• Willingness to attend at least two design sessions
• Willingness to attend one usability testing session, and participate in a post-usability survey and exit interview.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Single Arm Intervention Study

Experimental group

Description:

All participants will receive individualized text messages based on a schedule determined during the development and refinement of the mHealth text messaging intervention (i.e., once or twice a week). All participants will receive text messages for: 1) medication reminders, 2) appointment reminders, and 3) text messages addressing barriers (educational information to improve HIV knowledge) or promoting facilitators (e.g., routinizing taking of HIV antiretroviral medication) of care engagement. Each participant will complete baseline assessments, and will select their preferences for personalized messages on the day of baseline assessments. Text messages will be deployed for the duration of the 30-day trial. Participants will be followed-up at the completion of the 30-day intervention. Each participant will be asked to complete a follow-up survey, including questions on the acceptability of the mHealth intervention.

Treatment:

Other: Text messaging